Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Selling, General & Admin history
Currency unavailable · from the income statement
No Selling, General & Admin data reported for this period type.
Selling, General & Admin vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $375.93M USD | +21.7% | +13.2% | 51.2% | |
| LTM Mar 2026 | $269.6M USD | +128.9% | +60.2% | 796.2% | |
| LTM Mar 2026 | $206.83M USD | -15.5% | +17.1% | 26.0% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | +21.7% | +17.1% | 51.2% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.